Hero Image

Ulcerative colitis: signs, symptoms, and treatments

Ulcerative colitis is a chronic inflammation of the colon that can seriously impact daily life.

This guide explains how to spot the signs early, what symptoms to watch, where Mesalazine fits into treatment, and when to seek medical help—so you can make informed choices and feel more in control.

What is ulcerative colitis?

Ulcerative colitis (UC) is a form of inflammatory bowel disease (IBD) that causes continuous inflammation and ulcers in the lining of the large intestine (colon and rectum). It typically follows a relapsing–remitting course, with symptom flares followed by periods of remission. For a clear overview, see the NHS guide to ulcerative colitis.

Signs and symptoms of ulcerative colitis

Symptoms vary with the extent and severity of inflammation, but commonly include rectal bleeding, diarrhea (often with mucus), abdominal cramping, and a frequent, urgent need to pass stool. Fatigue and unintended weight loss can occur over time, particularly during flares. For a quick reference on typical symptoms, visit the Mayo Clinic overview.

Some people also experience symptoms beyond the gut (called extraintestinal manifestations), such as joint pain, skin rashes, mouth ulcers, and eye inflammation. Seek urgent care if you have severe abdominal pain, high fever, signs of dehydration, or heavy rectal bleeding, as these can signal a severe flare.

  • Rectal bleeding or blood in the stool
  • Diarrhea, often persistent and urgent
  • Abdominal cramping, bloating, and tenesmus (feeling of incomplete emptying)
  • Fatigue, low appetite, and unintended weight loss
  • Extraintestinal symptoms: joint pain, skin and eye irritation

UC often progresses from the rectum upward. In limited disease (proctitis), bleeding and urgency may dominate; more extensive disease tends to cause more frequent stools and pain. Tracking your symptoms—frequency, blood, nighttime stools, and urgency—can help your clinician assess severity.

When to see a doctor

Call your GP or gastroenterologist if you notice new or worsening rectal bleeding, persistent diarrhea (more than a few days), escalating urgency, or unexplained weight loss. If you develop severe pain, persistent fever, fainting, or signs of dehydration, seek urgent care. The NHS UC page outlines when to get help.

  • New rectal bleeding or mucus with stool
  • More than 4–6 bowel movements daily for several days
  • Severe urgency, incontinence, or nighttime stools
  • Fever, rapid heart rate, or significant abdominal pain
  • Signs of anemia (pale skin, dizziness) or dehydration

How ulcerative colitis is diagnosed

Diagnosis combines your history and exam with tests that look for inflammation and rule out infections. A stool test (including faecal calprotectin) helps differentiate inflammatory bowel disease from irritable bowel syndrome; learn more from Crohn’s & Colitis UK.

Blood tests (CRP, ESR, complete blood count, iron studies) assess inflammatory burden and anemia. A colonoscopy with biopsies confirms the diagnosis and defines disease extent; the endoscopist looks for continuous inflammation starting at the rectum. You can read what to expect from a colonoscopy on the NHS colonoscopy page.

Treatment goals and options

Treatment aims to induce remission (calm a flare) and maintain remission (prevent the next one), while minimizing side effects. Your plan depends on severity, disease extent, prior therapies, and personal preferences. National guidance such as NICE NG130 and specialty society guidelines inform therapy choices.

Mesalazine (5‑ASA): how it works and who it helps

Mesalazine (also called mesalamine or 5‑aminosalicylic acid/5‑ASA) is a topical anti‑inflammatory medicine that acts directly on the bowel lining to reduce cytokine and prostaglandin activity. It’s a first‑line therapy for mild to moderate UC, especially effective in disease limited to the rectum and left side of the colon. The AGA guideline for mild–moderate UC and a Cochrane review support its efficacy for inducing and maintaining remission.

Forms include oral tablets/capsules (various release profiles to target the colon) and rectal preparations (suppositories, foams, enemas) that deliver medicine directly to inflamed areas. For left‑sided disease or proctitis, combining oral + rectal mesalazine induces remission more effectively than either alone, and using rectal 5‑ASA is often key for controlling urgency and bleeding. Typical total daily oral doses range from 2–4.8 g/day for induction, with lower doses for maintenance—your clinician will tailor the regimen to your needs. See the NHS mesalazine overview for patient‑friendly detail.

Safety and monitoring. Mesalazine is generally well tolerated. Common effects include headache, nausea, mild abdominal discomfort, or gas; rare reactions include kidney issues (interstitial nephritis) or pancreatitis. Your team may check kidney function periodically. Report new rash, chest pain, severe abdominal pain, or dark urine promptly. Mesalazine is often continued long‑term to prevent relapse, and adherence (taking it daily, even when you feel well) substantially reduces flare risk.

Practical tips to make mesalazine work better:

  • Match the formulation to disease location: suppositories for proctitis; enemas or foam for left‑sided colitis.
  • Use oral + rectal therapy during flares when recommended—many patients notice faster relief of urgency and bleeding.
  • Build a daily habit (phone reminders, pill boxes) to improve adherence and maintain remission.

Other medication options

Corticosteroids (e.g., prednisolone) can induce remission in moderate flares but are not for maintenance because of side effects; a colon‑targeted steroid like budesonide MMX may help in milder disease with fewer systemic effects (NICE evidence summary).

Immunomodulators (azathioprine, 6‑mercaptopurine) help maintain remission, especially after steroid‑responsive flares, but require blood monitoring and time to work. Increasingly, clinicians use biologics and small molecules earlier for moderate–severe UC: anti‑TNF agents (infliximab, adalimumab), vedolizumab, ustekinumab, and JAK inhibitors (tofacitinib, upadacitinib). Therapy is individualized using a treat‑to‑target approach aimed at symptom control and mucosal healing; see high‑level summaries in ECCO guidelines and safety updates for JAK inhibitors from the FDA.

Non‑drug support that makes a difference

Nutrition. No single diet cures UC, but tailored adjustments can reduce symptoms: a lower‑residue approach during flares, gradual fibre reintroduction in remission, and attention to lactose or high‑FODMAP triggers (case‑by‑case). Practical ideas and meal planning tips are available from the Crohn’s & Colitis Foundation.

Lifestyle and prevention. Keep vaccinations current (especially before immunosuppressive therapy), avoid NSAIDs if they worsen symptoms, manage stress, and stay active as tolerated. The CDC offers general resources on living with IBD and prevention topics: CDC IBD resources. If flares affect mood or sleep, consider counseling or support groups—start with the Foundation’s mental health hub.

When surgery is considered

Surgery can be curative for colitis because the disease is limited to the colon. It’s considered for severe, refractory disease, complications (toxic megacolon, perforation), high‑grade dysplasia/cancer, or when medications cause unacceptable side effects. Options include total proctocolectomy with ileal pouch–anal anastomosis (IPAA) or with a permanent ileostomy. Learn more from the American Society of Colon & Rectal Surgeons (ASCRS).

Why early recognition and treatment matter

Early diagnosis and proactive treatment help control inflammation before it escalates, lowering the risk of hospitalization, steroid dependence, and complications. Achieving mucosal healing is linked to fewer relapses and better quality of life. Over the long term, controlling chronic inflammation also reduces the risk of colorectal cancer and may lessen the need for surgery; see patient guidance on risks and monitoring from Crohn’s & Colitis UK.

Practical next steps if you suspect UC

  • Track your symptoms (stool frequency, bleeding, urgency, night stools) and any triggers. Share this at appointments.
  • Arrange an evaluation with your GP to test for inflammation and infections; ask about faecal calprotectin and blood tests.
  • Discuss first‑line options, including oral and rectal mesalazine for mild–moderate disease, and how to use them effectively.
  • If symptoms are moderate–severe or not improving, ask about step‑up therapy (steroids, biologics) guided by current guidelines.
  • Prioritize vaccinations and infection screening before starting immunosuppressants; your care team will advise timing.
  • Build a support plan: nutrition strategies, stress management, and regular follow‑up to aim for remission and mucosal healing.

FAQs

Is ulcerative colitis the same as Crohn’s disease?

No. Both are forms of IBD, but UC affects the colon in a continuous pattern starting at the rectum, while Crohn’s can involve any part of the GI tract in a patchy pattern and may penetrate deeper layers.

Can diet cure UC?

Diet alone does not cure UC, but thoughtful adjustments can minimize symptoms and support overall health. Work with your clinician or a dietitian, and use reputable resources like the Crohn’s & Colitis Foundation.

Is mesalazine safe during pregnancy?

Mesalazine is generally considered low risk in pregnancy and breastfeeding; never stop or start medicines without discussing with your clinician. See patient information on the NHS mesalazine page and make a shared plan with your care team.

This article is educational and not a substitute for personalized medical advice. If you’re worried about symptoms, contact your GP or specialist.